We are live on !
Find out more
CQS Cayman Portfolio holdings
AUM
$2.26B
Turnover
34.41%
1-Year Est. Return
1.31%
This Fund
S&P 500
This Quarter Est. Return
-0.81%
1 Year Est. Return
+1.31%
3 Year Est. Return
+15.29%
5 Year Est. Return
+28.07%
10 Year Est. Return
–
AUM
$1.13B
AUM Growth
+$134M
(+13%)
Cap. Flow
-$487M
Cap. Flow % of AUM
Cap. Flow %
-42.97%
Top 10 Holdings %
Top 10 Hldgs %
43.31%
Holding
150
New
37
Increased
4
Reduced
28
Closed
19
Avg Time Held
Equity + Options
0.7
years
Top 10 Avg Time Held
Equity + Options
0.5
years
Top 20 Avg Time Held
Equity + Options
0.5
years
Avg Time Held Equity only
0.7
years
Top 10 Avg Time Held Equity only
0.5
years
Top 20 Avg Time Held Equity only
0.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Under Armour Class C
UA
|
+$53M |
| 2 |
Amicus Therapeutics
FOLD
|
+$9.7M |
| 3 |
Alnylam Pharmaceuticals
ALNY
|
+$8.8M |
| 4 |
ARIA
Ariad Pharmaceuticals Inc
ARIA
|
+$8.49M |
| 5 |
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
|
+$8.47M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Carnival Corporation Ltd
CCL
|
+$51.4M |
| 2 |
Ryanair
RYAAY
|
+$23.3M |
| 3 |
Liberty Latin America Class A
LILA
|
+$11.5M |
| 4 |
NSM
Nationstar Mortgage Holdings
NSM
|
+$10.5M |
| 5 |
AGN
Allergan plc
AGN
|
+$8.69M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 65.1% |
| 2 | Healthcare | 13.76% |
| 3 | Consumer Discretionary | 8.69% |
| 4 | Communication Services | 4.23% |
| 5 | Technology | 3.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Under Armour Class C
UA
$1.95B
| $52.3M | 4.62% |
+1,437,955
| New | +$53M |
2016 Q2
0 quarters
|
|
|
AGN
2
DELISTED
Allergan plc
AGN
| $41.5M | 3.66% |
179,639
-37,708
| -17% | -$8.69M |
2015 Q4
2 quarters
|
|
|
3
Carnival Corporation Ltd
CCL
$35B
| $24.1M | 2.13% |
547,815
-1,047,474
| -66% | -$51.4M |
2015 Q1
5 quarters
|
|
|
LVNTA
4
DELISTED
Liberty Interactive Corporation Series A Liberty Ventures
LVNTA
| $14.4M | 1.27% |
389,769
+198,574
| +104% | +$7.55M |
2015 Q2
4 quarters
|
|
5
Zoetis
ZTS
$33.4B
| $9.8M | 0.86% |
205,995
-74,400
| -27% | -$3.51M |
2015 Q1
5 quarters
|
|
6
Altisource Portfolio Solutions
ASPS
$62.8M
| $9.7M | 0.86% |
43,750
-3,378
| -7% | -$748K |
2015 Q2
4 quarters
|
|
7
DELISTED
Walgreens Boots Alliance
WBA
| $8.79M | 0.78% |
105,550
+93,050
| +744% | +$7.51M |
2016 Q1
1 quarter
|
|
|
AET
8
DELISTED
Aetna Inc
AET
| $8.55M | 0.75% |
70,012
-13,000
| -16% | -$1.49M |
2015 Q4
2 quarters
|
|
|
ARIA
9
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $8.36M | 0.74% |
+1,132,000
| New | +$8.49M |
2016 Q2
0 quarters
|
|
|
10
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
| $8.34M | 0.74% |
+354,813
| New | +$8.47M |
2016 Q2
0 quarters
|
|
11
Teva Pharmaceutical Industries Limited
TEVA
$46.2B
| $8.31M | 0.73% |
165,389
-47,047
| -22% | -$2.5M |
2015 Q4
2 quarters
|
|
12
Atlassian
TEAM
$56.7B
| $7.88M | 0.7% |
304,285
| – | – |
2015 Q4
2 quarters
|
|
|
13
Alnylam Pharmaceuticals
ALNY
$30.4B
| $7.75M | 0.68% |
+139,680
| New | +$8.8M |
2016 Q2
0 quarters
|
|
14
Liberty Global Class A
LBTYA
$2.67B
| $7.73M | 0.68% |
266,122
-173,210
| -39% | -$5.62M |
2016 Q1
1 quarter
|
|
|
15
DELISTED
Amicus Therapeutics
FOLD
| $7.59M | 0.67% |
+1,390,000
| New | +$9.7M |
2016 Q2
0 quarters
|
|
16
DELISTED
Radius Health, Inc.
RDUS
| $7.35M | 0.65% |
+200,000
| New | +$7.06M |
2016 Q2
0 quarters
|
|
|
ONCE
17
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $6.89M | 0.61% |
+134,669
| New | +$5.75M |
2016 Q2
0 quarters
|
|
|
MON
18
DELISTED
Monsanto Co
MON
| $6.68M | 0.59% |
64,649
-9,100
| -12% | -$901K |
2015 Q3
3 quarters
|
|
19
Liberty Media Corporation Series C Common Stock
FWONK
$22.5B
| $6.66M | 0.59% |
363,225
+52,937
| +17% | +$1.03M |
2015 Q3
3 quarters
|
|
20
Zimmer Biomet
ZBH
$18.6B
| $6.57M | 0.58% |
56,206
-6,219
| -10% | -$704K |
2016 Q1
1 quarter
|
|
|
STJ
21
DELISTED
St Jude Medical
STJ
| $6.55M | 0.58% |
+84,000
| New | +$5.99M |
2016 Q2
0 quarters
|
|
|
EPZM
22
DELISTED
Epizyme, Inc
EPZM
| $6.5M | 0.57% |
+635,000
| New | +$7.08M |
2016 Q2
0 quarters
|
|
23
McKesson
MCK
$117B
| $6.18M | 0.55% |
33,098
-12,318
| -27% | -$2.16M |
2016 Q1
1 quarter
|
|
|
GRA
24
DELISTED
W.R. Grace & Co.
GRA
| $5.3M | 0.47% |
72,465
-24,800
| -25% | -$1.9M |
2015 Q4
2 quarters
|
|
25
Constellium
CSTM
$3.15B
| $5.21M | 0.46% |
1,110,000
| – | – |
2016 Q1
1 quarter
|
|
Similar funds
RCM
GVI
TAM
AWM
CQS Cayman's Q2 2016 Portfolio in Review
As of Q2 2016, CQS Cayman held 150 positions worth $1.13B, up 13% from $1000M the previous quarter. Its ten largest holdings account for 43% of the portfolio.
CQS Cayman withdrew a net $487M in Q2 2016, closing 19 positions and reducing 28 holdings. Its most notable exit was Ryanair, an estimated $23.3M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 65% of assets, up from 57% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, CQS Cayman opened a new position in Under Armour Class C worth $52.3M.
- CQS Cayman's largest Q2 2016 buy was Under Armour Class C: 1,437,955 shares worth $52.3M.
- CQS Cayman added most to Liberty Interactive Corporation Series A Liberty Ventures in Q2 2016, an estimated $7.55M increase.
- CQS Cayman's biggest Q2 2016 reduction was Carnival Corporation Ltd, cutting an estimated $51.4M.
- CQS Cayman fully exited Ryanair in Q2 2016, selling an estimated $23.3M.
- CQS Cayman's ten largest holdings make up 43% of its $1.13B portfolio in Q2 2016.
- CQS Cayman opened 37 new positions and closed 19 in Q2 2016.
- CQS Cayman's portfolio value rose 13% quarter-over-quarter to $1.13B.
Based on CQS Cayman's 13F filing for Q2 2016, filed 9 Aug 2016.